Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Times Interest Earned (2022 - 2025)

Arrowhead Pharmaceuticals' Times Interest Earned history spans 4 years, with the latest figure at $1.81 for Q4 2025.

  • For Q4 2025, Times Interest Earned rose 124.32% year-over-year to $1.81; the TTM value through Dec 2025 reached $3.33, up 125.88%, while the annual FY2025 figure was $1.1, 105.92% up from the prior year.
  • Times Interest Earned reached $1.81 in Q4 2025 per ARWR's latest filing, down from $2.03 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $17.62 in Q1 2025 to a low of -$34.58 in Q2 2024.
  • Average Times Interest Earned over 4 years is -$9.77, with a median of -$11.07 recorded in 2024.
  • Peak YoY movement for Times Interest Earned: plummeted 282.9% in 2024, then surged 201.13% in 2025.
  • A 4-year view of Times Interest Earned shows it stood at -$14.79 in 2022, then tumbled by 72.03% to -$25.44 in 2023, then skyrocketed by 70.69% to -$7.46 in 2024, then skyrocketed by 124.32% to $1.81 in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Times Interest Earned are $1.81 (Q4 2025), $2.03 (Q3 2025), and -$6.79 (Q2 2025).